Blog
New
Transforming Molecular Testing
Transforming Molecular Testing
Rita Bhui
5 Min Read
Share
Introduction and Significance
Cancer is caused by changes in the DNA of cells. Studying these genetic changes, known as cancer genomics, helps doctors diagnose cancer accurately, predict how it will progress, and choose the best treatments for each patient. As we learn more about the complex genetics of tumors, there is a growing need for fast, affordable, and large-scale genetic testing. But testing many genes in many patients at once is still difficult and expensive.
Current Technologies: Cancer Genomics
Modern cancer genomics relies on several powerful technologies to decode the genetic makeup of tumors:
Next-Generation Sequencing (NGS): Enables rapid sequencing of DNA and RNA, uncovering mutations, copy number changes, and gene fusions.
Whole Genome and Whole Exome Sequencing: Provide comprehensive or focused views of genetic alterations in cancer cells.
Targeted Gene Panels: Focus on known cancer-related genes for efficient mutation screening.
Single-cell Sequencing: Captures tumor heterogeneity at cellular resolution.
Liquid Biopsies: Detect circulating tumor DNA non-invasively for monitoring disease progression.
Together, these technologies have advanced precision oncology, allowing clinicians to tailor treatments based on individual tumor profiles.
Challenges
Despite these advances, cancer genomics faces several major challenges:
High complexity and scale: Testing large numbers of genetic targets across many samples requires extensive reagents, time, and labor.
Cost barriers: Comprehensive panels and repeated testing are expensive and limit widespread adoption.
Data noise and accuracy: High multiplexing can introduce errors and reduce sensitivity.
Workflow complexity: Multiple rounds of testing or complicated protocols increase turnaround time.
Limited accessibility: Many labs lack the infrastructure or resources to perform large-scale genomic assays routinely.
These barriers slow down the translation of genomic insights into routine patient care.
How Tapestry Can Add Value
Tapestry by Algorithmic Biologics offers a revolutionary solution to overcome these challenges and unlock the full potential of cancer genomics:
Efficient and Scalable Genomic Profiling
Cancer genomics requires analyzing hundreds to thousands of genetic mutations across many patient samples to enable precision oncology. Tapestry's patented algorithmic pooling strategy combines multiple tumor samples into structured pools, enabling high-throughput sequencing with significantly reduced reagent consumption and cost. This scalable approach makes comprehensive cancer genomic profiling more practical for routine clinical use and large-scale research studies.Enhanced Confidence in Variant Detection
Finding the right mutations is very important for cancer treatment. Tapestry includes each tumor sample in several different pools. This means real mutations show up in multiple pools, while random errors usually do not. This built-in repetition helps reduce mistakes and makes the test results more accurate, helping doctors make better treatment decisions.
Conclusion
Cancer genomics is key to personalized cancer treatment, but current testing methods can be costly and complex. Tapestry changes the game by providing scalable, accurate, and affordable testing that fully utilizes genetic information to improve patient care.
With Tapestry, precision oncology becomes more accessible, helping more patients get the right treatment faster and driving new discoveries in cancer research.
More Article
Introduction and Significance
Cancer is caused by changes in the DNA of cells. Studying these genetic changes, known as cancer genomics, helps doctors diagnose cancer accurately, predict how it will progress, and choose the best treatments for each patient. As we learn more about the complex genetics of tumors, there is a growing need for fast, affordable, and large-scale genetic testing. But testing many genes in many patients at once is still difficult and expensive.
Current Technologies: Cancer Genomics
Modern cancer genomics relies on several powerful technologies to decode the genetic makeup of tumors:
Next-Generation Sequencing (NGS): Enables rapid sequencing of DNA and RNA, uncovering mutations, copy number changes, and gene fusions.
Whole Genome and Whole Exome Sequencing: Provide comprehensive or focused views of genetic alterations in cancer cells.
Targeted Gene Panels: Focus on known cancer-related genes for efficient mutation screening.
Single-cell Sequencing: Captures tumor heterogeneity at cellular resolution.
Liquid Biopsies: Detect circulating tumor DNA non-invasively for monitoring disease progression.
Together, these technologies have advanced precision oncology, allowing clinicians to tailor treatments based on individual tumor profiles.
Challenges
Despite these advances, cancer genomics faces several major challenges:
High complexity and scale: Testing large numbers of genetic targets across many samples requires extensive reagents, time, and labor.
Cost barriers: Comprehensive panels and repeated testing are expensive and limit widespread adoption.
Data noise and accuracy: High multiplexing can introduce errors and reduce sensitivity.
Workflow complexity: Multiple rounds of testing or complicated protocols increase turnaround time.
Limited accessibility: Many labs lack the infrastructure or resources to perform large-scale genomic assays routinely.
These barriers slow down the translation of genomic insights into routine patient care.
How Tapestry Can Add Value
Tapestry by Algorithmic Biologics offers a revolutionary solution to overcome these challenges and unlock the full potential of cancer genomics:
Efficient and Scalable Genomic Profiling
Cancer genomics requires analyzing hundreds to thousands of genetic mutations across many patient samples to enable precision oncology. Tapestry's patented algorithmic pooling strategy combines multiple tumor samples into structured pools, enabling high-throughput sequencing with significantly reduced reagent consumption and cost. This scalable approach makes comprehensive cancer genomic profiling more practical for routine clinical use and large-scale research studies.Enhanced Confidence in Variant Detection
Finding the right mutations is very important for cancer treatment. Tapestry includes each tumor sample in several different pools. This means real mutations show up in multiple pools, while random errors usually do not. This built-in repetition helps reduce mistakes and makes the test results more accurate, helping doctors make better treatment decisions.
Conclusion
Cancer genomics is key to personalized cancer treatment, but current testing methods can be costly and complex. Tapestry changes the game by providing scalable, accurate, and affordable testing that fully utilizes genetic information to improve patient care.
With Tapestry, precision oncology becomes more accessible, helping more patients get the right treatment faster and driving new discoveries in cancer research.
More Article
Introduction and Significance
Cancer is caused by changes in the DNA of cells. Studying these genetic changes, known as cancer genomics, helps doctors diagnose cancer accurately, predict how it will progress, and choose the best treatments for each patient. As we learn more about the complex genetics of tumors, there is a growing need for fast, affordable, and large-scale genetic testing. But testing many genes in many patients at once is still difficult and expensive.
Current Technologies: Cancer Genomics
Modern cancer genomics relies on several powerful technologies to decode the genetic makeup of tumors:
Next-Generation Sequencing (NGS): Enables rapid sequencing of DNA and RNA, uncovering mutations, copy number changes, and gene fusions.
Whole Genome and Whole Exome Sequencing: Provide comprehensive or focused views of genetic alterations in cancer cells.
Targeted Gene Panels: Focus on known cancer-related genes for efficient mutation screening.
Single-cell Sequencing: Captures tumor heterogeneity at cellular resolution.
Liquid Biopsies: Detect circulating tumor DNA non-invasively for monitoring disease progression.
Together, these technologies have advanced precision oncology, allowing clinicians to tailor treatments based on individual tumor profiles.
Challenges
Despite these advances, cancer genomics faces several major challenges:
High complexity and scale: Testing large numbers of genetic targets across many samples requires extensive reagents, time, and labor.
Cost barriers: Comprehensive panels and repeated testing are expensive and limit widespread adoption.
Data noise and accuracy: High multiplexing can introduce errors and reduce sensitivity.
Workflow complexity: Multiple rounds of testing or complicated protocols increase turnaround time.
Limited accessibility: Many labs lack the infrastructure or resources to perform large-scale genomic assays routinely.
These barriers slow down the translation of genomic insights into routine patient care.
How Tapestry Can Add Value
Tapestry by Algorithmic Biologics offers a revolutionary solution to overcome these challenges and unlock the full potential of cancer genomics:
Efficient and Scalable Genomic Profiling
Cancer genomics requires analyzing hundreds to thousands of genetic mutations across many patient samples to enable precision oncology. Tapestry's patented algorithmic pooling strategy combines multiple tumor samples into structured pools, enabling high-throughput sequencing with significantly reduced reagent consumption and cost. This scalable approach makes comprehensive cancer genomic profiling more practical for routine clinical use and large-scale research studies.Enhanced Confidence in Variant Detection
Finding the right mutations is very important for cancer treatment. Tapestry includes each tumor sample in several different pools. This means real mutations show up in multiple pools, while random errors usually do not. This built-in repetition helps reduce mistakes and makes the test results more accurate, helping doctors make better treatment decisions.
Conclusion
Cancer genomics is key to personalized cancer treatment, but current testing methods can be costly and complex. Tapestry changes the game by providing scalable, accurate, and affordable testing that fully utilizes genetic information to improve patient care.
With Tapestry, precision oncology becomes more accessible, helping more patients get the right treatment faster and driving new discoveries in cancer research.